Researchers have uncovered the role of an immune response, previously attributed only to inflammatory conditions, in asthma symptoms.
This immune response, “Th17”, is coordinated by a specific type of white blood cell that produced molecules that damage the lungs. This disrupts the lung’s control mechanisms that would prevent asthma in healthy individuals.
The new research could guide the creation of new medicines to block this immune response in people who experience severe asthma.
Tom Hennessy
Retired
If one looks closely , one will notice one thing common to asthma patients. Increased red blood cell production , erythrocytosis , polycythemia. Everyone says the increased red blood cell production is due to their lack of oxygen FROM the asthma , but , the drugs used decrease red blood cell production when used in OTHER disease states. So , in effect , they tell us the drugs DON'T specifically target the increased red blood cells , but , give drugs which decrease red blood cells.
Read more"Dexamethasone…